跳至主要内容
临床试验/KCT0000266
KCT0000266已完成未知

The Evaluation of Effectiveness and Safety for New Therapy with Bone Marrow derived Autologous Mesenchymal Stem Cell for Hepatic Failure caused by Alcoholic Liver Cirrhosis

Yonsei University, Wonju Severance Christian Hospital0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 60(Year)(—)
性别
All

入选标准

  • (1) Alcoholic liver cirrhosis(child Pugh class B or C, = 7 scores)
  • , confirmed by clinically or biopsy.
  • (2) Stop drinking over past 6months.
  • (3) Patients agree with informed consent
  • Patients must satisfy all inclusion criteria.

排除标准

  • (1) Patients who did not satisfy inclusion criteria
  • (2) Hepatocellular carcinoma
  • (3) Pregnancy or breast feeding
  • (4) Infective disease(HIV, HBV, HCV..)
  • (5) Other incurable malignancy

研究者

发起方
Yonsei University, Wonju Severance Christian Hospital

相似试验